GO:0089701 U2AF complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0089701 defines the U2AF complex, a heterodimeric cellular_component consisting of a large and a small subunit that binds consensus sequences at the 3' splice site and stabilizes U2 snRNP association with the branch point.
• The U2AF complex is essential for spliceosomal RNA splicing and is conserved from fission yeast to humans, where SF1-U2AF59-U2AF23 forms a stable pre-spliceosome complex.
• U2AF2 (U2AF65) is the large subunit that recognizes the polypyrimidine tract, while U2AF1 (U2AF35) is the small subunit that binds the AG dinucleotide at the 3' splice site.
• Somatic mutations in U2AF1 are recurrent in myeloid malignancies including acute myeloid leukemia and chronic neutrophilic leukemia, linking the complex to cancer ontogeny.
• U2AF2 dysregulation promotes pulmonary hypertension through super-enhancer-driven HCG20 and altered splicing, demonstrating disease relevance beyond cancer.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable functional dissection of U2AF complex subunits in splicing and disease.
Description
The U2AF complex (GO:0089701) is a heterodimeric cellular_component that contributes to spliceosomal RNA splicing by binding consensus sequences at the 3' splice site and stabilizing the association of U2 snRNP with the branch point. It is composed of a conserved large subunit and a conserved small subunit, and its activity is required for the earliest steps of spliceosome assembly. In fission yeast, pre-spliceosome formation requires a stable complex of SF1-U2AF59-U2AF23, establishing the evolutionary conservation of this module. The U2AF complex is therefore a central node in RNA processing, and its dysfunction has been linked to hematologic malignancies and other diseases. Researchers study GO:0089701 to understand how 3' splice site selection is controlled and how splicing errors contribute to human disease.
U2AF complex At A Glance
| GO ID | GO:0089701 |
|---|---|
| GO term | U2AF complex |
| Ontology | cellular_component |
| Synonym | U2 accessory factor, U2AF |
| Definition | A heterodimeric protein complex consisting of conserved large and small U2AF subunits that contributes to spliceosomal RNA splicing by binding to consensus sequences at the 3' splice site. U2AF is required to stabilize the association of the U2 snRNP with the branch point. |
| Major function | 3' splice site recognition and stabilization of U2 snRNP at the branch point during spliceosome assembly |
| Subunit composition | Large subunit (U2AF2/U2AF65) and small subunit (U2AF1/U2AF35) |
| Conservation | Conserved from Schizosaccharomyces pombe to humans; SF1-U2AF59-U2AF23 pre-spliceosome complex in S. pombe |
| Related pathway | Spliceosomal RNA splicing; pre-spliceosome (E complex) assembly |
What Is GO:0089701?
According to the QuickGO definition, GO:0089701 (U2AF complex) is a heterodimeric protein complex consisting of conserved large and small U2AF subunits that contributes to spliceosomal RNA splicing by binding to consensus sequences at the 3' splice site. U2AF is required to stabilize the association of the U2 snRNP with the branch point. In practical terms, the complex acts as a 3' splice site recognition module that helps the spliceosome commit to a correct intron boundary before catalysis.
Why Is U2AF complex Important in Cell Biology?
The U2AF complex is important because it governs a decisive step in spliceosome assembly: recognition of the 3' splice site and stabilization of U2 snRNP at the branch point. Without this function, introns cannot be efficiently defined, and splicing fidelity is compromised. Because splicing affects nearly every cellular process, mutations or dysregulation of U2AF subunits can have broad consequences, including clonal hematopoiesis and leukemia. Understanding GO:0089701 therefore informs both basic RNA biology and translational research in cancer and other diseases.
• Defines the 3' splice site and is required for stable U2 snRNP association with the branch point.
• Conserved across eukaryotes, enabling mechanistic studies in model organisms such as S. pombe.
• Recurrently mutated in myeloid malignancies, including acute myeloid leukemia and chronic neutrophilic leukemia.
• Implicated in clonal hematopoiesis and telomere biology disorders through somatic mutations.
• Dysregulated in pulmonary hypertension via super-enhancer-driven HCG20 and U2AF2 splicing.
• Contributes to stochastic splice site selection and transcription-coupled splicing dynamics.
• Provides a target for CRISPR-based functional genomics of splicing factors.
• Serves as a model for studying RNA-protein interactions and spliceosome assembly intermediates.
What Happens During U2AF complex?
Recognition of the 3' splice site
In simple terms: The U2AF complex first finds and binds the end of the intron that will be cut.
The U2AF complex binds consensus sequences at the 3' splice site, including the polypyrimidine tract and the AG dinucleotide, thereby marking the intron boundary for the splicing machinery. This binding is an early and essential step in spliceosome assembly, and it helps define which sequences will be treated as introns.
Stabilization of U2 snRNP at the branch point
In simple terms: After binding the 3' splice site, U2AF helps hold the U2 snRNP in place so splicing can proceed.
U2AF is required to stabilize the association of the U2 snRNP with the branch point, a prerequisite for pre-spliceosome formation. In S. pombe, pre-spliceosome formation requires a stable complex of SF1-U2AF59-U2AF23, showing that U2AF acts together with SF1 to commit the intron to splicing.
Commitment complex and splice site selection
In simple terms: The cell decides which splice sites to use, and U2AF is part of that decision-making machinery.
A U2AF-independent commitment complex (E') has been characterized in the mammalian spliceosome assembly pathway, indicating that U2AF functions within a broader network of commitment factors that influence splice site selection. Dynamic imaging of nascent RNA has revealed general principles of transcription dynamics and stochastic splice site selection, providing a framework for understanding how U2AF-dependent recognition contributes to splicing outcomes.
Coupling to downstream splicing catalysis
In simple terms: Once U2AF has done its job, the spliceosome can carry out the chemical steps of splicing.
By stabilizing U2 snRNP at the branch point, the U2AF complex enables the subsequent assembly and catalytic activation of the spliceosome. RNA-protein interactions underlying this recognition are governed by principles of nucleic acid binding specificity and affinity, which determine how U2AF engages its RNA targets.
Key Genes Involved in GO:0089701 U2AF complex
The following genes and proteins are central to the composition, regulation, and study of the U2AF complex (GO:0089701).
| Gene | Major Role | Research Relevance |
|---|---|---|
| U2AF2 | Large subunit of U2AF; binds polypyrimidine tract at 3' splice site | Dysregulated in pulmonary hypertension via HCG20 super-enhancer |
| U2AF1 | Small subunit of U2AF; binds AG dinucleotide at 3' splice site | Recurrently mutated in AML and chronic neutrophilic leukemia |
| SF1 | Splicing factor 1; forms stable complex with U2AF59 and U2AF23 in S. pombe | Required for pre-spliceosome formation |
| U2AF59 | S. pombe large U2AF subunit | Component of SF1-U2AF59-U2AF23 pre-spliceosome complex |
| U2AF23 | S. pombe small U2AF subunit | Component of SF1-U2AF59-U2AF23 pre-spliceosome complex |
| U2 snRNP | Small nuclear ribonucleoprotein stabilized at branch point by U2AF | Essential for spliceosome assembly |
| HCG20 | Super-enhancer-driven lncRNA promoting pulmonary hypertension via U2AF2 | Links U2AF2 splicing to vascular disease |
| SF3B1 | Spliceosome component frequently mutated in myeloid neoplasms | Context for U2AF1 mutation studies in leukemia |
| SRSF2 | Serine/arginine-rich splicing factor | Co-mutated with U2AF1 in myeloid malignancies |
| DNMT3A | Epigenetic regulator | Clonal hematopoiesis context for U2AF1 mutations |
| TET2 | Epigenetic regulator | Clonal hematopoiesis context for spliceosome mutations |
| ASXL1 | Chromatin modifier | Co-mutated with U2AF1 in chronic neutrophilic leukemia |
| SETBP1 | Transcription factor | Co-mutated with U2AF1 in chronic neutrophilic leukemia |
| CSF3R | Cytokine receptor | Co-mutated with U2AF1 in chronic neutrophilic leukemia |
| PRPF8 | Core spliceosome component | Comparative studies of spliceosome assembly |
| U2AF65 | Alternative name for U2AF2 large subunit | RNA-binding studies of 3' splice site recognition |
| U2AF35 | Alternative name for U2AF1 small subunit | Mutation studies in myeloid malignancies |
How Is U2AF complex Regulated?
The U2AF complex is regulated at multiple levels. Its large subunit U2AF2 can be driven by super-enhancer activity, as shown for HCG20 in pulmonary hypertension, where super-enhancer-driven HCG20 promotes disease through U2AF2 splicing. Somatic mutations in U2AF1 alter its function and are subject to clonal selection in hematopoietic tissue, as seen in acute myeloid leukemia and chronic neutrophilic leukemia. In telomere biology disorders, somatic mutations in spliceosome genes including U2AF1 can provide clonal rescue and influence cancer risk. At the RNA level, dynamic transcription and stochastic splice site selection influence how U2AF engages nascent transcripts. RNA-protein interaction principles further shape U2AF binding specificity and affinity.
U2AF complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| U2AF1 | Acute myeloid leukemia; chronic neutrophilic leukemia | Knockout and point-mutation cell models in hematopoietic lines |
| U2AF2 | Pulmonary hypertension | Overexpression and knockout models in pulmonary vascular cells |
| U2AF1 | Clonal hematopoiesis; telomere biology disorders | Knock-in of patient mutations in iPSC-derived hematopoietic cells |
| SF1 | Pre-spliceosome assembly defects | Knockout in S. pombe and mammalian cells |
| U2AF1 | Splicing fidelity and 3' splice site selection | Reporter assays and RNA-seq in edited cell lines |
U2AF complex mutations in myeloid malignancies
Somatic mutations in U2AF1, the small subunit of the U2AF complex, are recurrent in acute myeloid leukemia and define distinct ontogeny. In chronic neutrophilic leukemia, U2AF1 mutations co-occur with mutations in ASXL1, SETBP1, and CSF3R, contributing to disease genomics. These findings establish the U2AF complex as a clinically relevant splicing module in hematologic cancers.
Clonal hematopoiesis and telomere biology disorders
Somatic mutations in spliceosome genes, including U2AF1, can arise in the context of clonal hematopoiesis and telomere biology disorders, where they may provide somatic rescue but also increase cancer risk. This links U2AF complex dysfunction to age-related clonal expansion and bone marrow failure syndromes.
U2AF2 and pulmonary hypertension
Super-enhancer-driven HCG20 promotes pulmonary hypertension through U2AF2 splicing, demonstrating that U2AF complex dysregulation extends beyond cancer to vascular disease. This provides a rationale for targeting U2AF2-dependent splicing in pulmonary hypertension research.
From U2AF complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of U2AF1 impair spliceosome assembly? | U2AF1 knockout cell line |
| Do leukemia-associated U2AF1 mutations alter 3' splice site selection? | U2AF1 point-mutation knock-in cell line |
| Can wild-type U2AF2 rescue splicing defects? | U2AF2 overexpression and rescue model |
| How does U2AF2 localization change during disease? | Tagged knock-in of U2AF2 with fluorescent tag |
| Which transcripts depend on U2AF complex activity? | RNA-seq after U2AF1 or U2AF2 knockout |
| Does HCG20 regulate U2AF2 in pulmonary hypertension? | HCG20 overexpression and knockdown in vascular cells |
How to Study the U2AF complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Splicing patterns and gene expression | Detect 3' splice site changes after U2AF perturbation |
| Nascent RNA imaging | Transcription dynamics and splice site selection | Study stochastic splicing in live cells |
| Affinity purification-mass spectrometry | Protein complex composition | Identify U2AF-associated factors |
| RNA binding assays | Affinity and specificity for RNA motifs | Characterize U2AF-RNA interactions |
| CRISPR knockout | Loss-of-function phenotype | Test requirement for U2AF subunits |
| CRISPR point mutation | Effect of disease-associated mutations | Model U2AF1 mutations in leukemia |
| Overexpression | Gain-of-function and rescue | Study U2AF2 in pulmonary hypertension |
| Reporter splicing assays | Splice site usage | Measure commitment complex activity |
RNA-seq and splicing analysis
RNA-seq is used to measure changes in splicing patterns after perturbation of U2AF complex subunits, revealing altered 3' splice site usage and intron retention. Dynamic imaging of nascent RNA can complement RNA-seq by capturing transcription and splicing kinetics in real time.
Proteomics and complex purification
Affinity purification and mass spectrometry can identify U2AF complex components and associated factors such as SF1 and U2 snRNP proteins. These approaches help define the composition and assembly state of the complex.
RNA-protein interaction assays
Biochemical and structural approaches measure RNA-protein interactions that govern U2AF binding to the polypyrimidine tract and AG dinucleotide. Such assays define the affinity and specificity of U2AF for its RNA targets.
Functional genomics and CRISPR screens
CRISPR knockout and point-mutation screens can test the requirement for U2AF subunits in cell fitness and splicing. These methods link genotype to splicing phenotypes and disease-relevant outcomes.
How CRISPR Can Be Used to Study GO:0089701 U2AF complex
Knockout
CRISPR knockout of U2AF1 or U2AF2 can be used to test the requirement for the U2AF complex in spliceosome assembly and cell viability. Loss-of-function models help define which transcripts and pathways depend on U2AF activity.
Point Mutation
Point-mutation knock-in of leukemia-associated U2AF1 variants allows researchers to study how specific mutations alter 3' splice site selection and contribute to myeloid malignancy. These models are valuable for linking genotype to splicing phenotype.
Knock-in
Tagged knock-in of U2AF2 or U2AF1 enables imaging and biochemical tracking of the complex in live cells. Knock-in of patient-derived mutations can model clonal hematopoiesis and telomere biology disorders.
Overexpression
Overexpression of U2AF2 or HCG20 can model gain-of-function states such as pulmonary hypertension, where super-enhancer-driven HCG20 promotes disease through U2AF2 splicing. Overexpression rescue experiments can confirm specificity of splicing defects.
How EDITGENE Supports U2AF complex Research
Researchers studying U2AF complex-related genes often need to determine whether a candidate gene is causally involved in splicing regulation or disease. EDITGENE provides CRISPR-based cell model services that enable precise manipulation of U2AF1, U2AF2, SF1, and related splicing factors, allowing functional interrogation of GO:0089701 in relevant cellular contexts.
Contact EDITGENE today to design your custom CRISPR model for U2AF complex research.
Frequently Asked Questions About U2AF complex
What is the U2AF complex?
The U2AF complex (GO:0089701) is a heterodimeric protein complex of large and small U2AF subunits that binds consensus sequences at the 3' splice site and stabilizes U2 snRNP at the branch point during spliceosomal RNA splicing.
What genes are involved in the U2AF complex?
The core genes are U2AF2 (large subunit) and U2AF1 (small subunit), with SF1 and U2 snRNP components acting in the same assembly step.
What is the function of GO:0089701?
GO:0089701 functions in 3' splice site recognition and stabilization of U2 snRNP at the branch point, which is required for pre-spliceosome formation.
Is the U2AF complex conserved across species?
Yes, a stable SF1-U2AF59-U2AF23 complex is required for pre-spliceosome formation in Schizosaccharomyces pombe, showing conservation with mammals.
How is the U2AF complex linked to leukemia?
Somatic mutations in U2AF1 are recurrent in acute myeloid leukemia and chronic neutrophilic leukemia, where they define distinct disease ontogeny and co-occur with other mutations.
What diseases are associated with U2AF2?
U2AF2 dysregulation is associated with pulmonary hypertension through super-enhancer-driven HCG20 and altered splicing.
How can I study the U2AF complex in the lab?
Common approaches include RNA-seq, nascent RNA imaging, affinity purification-mass spectrometry, RNA binding assays, and CRISPR knockout or point-mutation models.
What CRISPR models are available for U2AF1?
Knockout, point-mutation knock-in, tagged knock-in, and overexpression models can be generated to study U2AF1 function and disease mutations.
Does the U2AF complex affect splice site selection?
Yes, U2AF contributes to 3' splice site recognition and commitment complex activity, influencing which splice sites are used.
Why is the U2AF complex important for RNA splicing?
It stabilizes U2 snRNP at the branch point, a required step for spliceosome assembly and catalytic activation.
Conclusion
The U2AF complex (GO:0089701) is a conserved heterodimeric cellular_component that recognizes the 3' splice site and stabilizes U2 snRNP at the branch point, making it essential for spliceosomal RNA splicing. Its subunits U2AF1 and U2AF2 are implicated in myeloid malignancies, clonal hematopoiesis, and pulmonary hypertension, underscoring its clinical relevance. CRISPR-based knockout, point-mutation, knock-in, and overexpression models provide powerful tools to dissect U2AF complex function and its role in disease.
References
- 1. Mei J et al.. 2025. Super-Enhancer-Driven HCG20 Promotes Pulmonary Hypertension Through U2AF2 Splicing.. Circ Res 137(3):e19-e39 PMID: 40433695
- 2. Lindsley RC et al.. 2015. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.. Blood 125(9):1367-76 PMID: 25550361
- 3. Wan Y et al.. 2021. Dynamic imaging of nascent RNA reveals general principles of transcription dynamics and stochastic splice site selection.. Cell 184(11):2878-2895.e20 PMID: 33979654
- 4. Huang T et al.. 2002. Pre-spliceosome formation in S.pombe requires a stable complex of SF1-U2AF(59)-U2AF(23).. EMBO J 21(20):5516-26 PMID: 12374752
- 5. Maxson JE et al.. 2017. Genomics of chronic neutrophilic leukemia.. Blood 129(6):715-722 PMID: 28028025
- 6. Hall KB. 2002. RNA-protein interactions.. Curr Opin Struct Biol 12(3):283-8 PMID: 12127445
- 7. Gutierrez-Rodrigues F et al.. 2024. Clonal landscape and clinical outcomes of telomere biology disorders: somatic rescue and cancer mutations.. Blood 144(23):2402-2416 PMID: 39316766
- 8. Kent OA et al.. 2005. Characterization of a U2AF-independent commitment complex (E') in the mammalian spliceosome assembly pathway.. Mol Cell Biol 25(1):233-40 PMID: 15601845
